Home › Funds › Point72 Asset Management › AMRX
Point72 Asset Management position in AMRX
AMNEAL PHARMACEUTICALS INC · Health Care
Latest position (Q1 2026)78.11K sh
Reported value held$970.85K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 3.75M | $20.00M | New |
| Q4 2021 | 3.31M | $15.86M | Reduce |
| Q1 2022 | 3.00M | $12.51M | Reduce |
| Q2 2022 | 3.46M | $11.02M | Add |
| Q3 2022 | 2.75M | $5.55M | Reduce |
| Q3 2023 | 124.00K | $523.28K | New |
| Q1 2024 | 60.50K | $366.63K | New |
| Q1 2025 | 446.00K | $3.74M | New |
| Q1 2026 | 78.11K | $970.85K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding AMRX
- BlackRock Inc 26.56M sh · $459.79M · Q2 2026
- Vanguard Group 17.91M sh · $225.64M · Q4 2025
- Geode Capital Management 5.14M sh · $88.98M · Q2 2026
- Morgan Stanley 4.11M sh · $71.14M · Q2 2026
- Invesco Ltd 3.50M sh · $60.62M · Q2 2026
- Goldman Sachs Group 3.01M sh · $52.17M · Q2 2026
- Charles Schwab Investment Management 2.15M sh · $37.17M · Q2 2026
- Northern Trust Corp 1.91M sh · $33.15M · Q2 2026
- Citadel Advisors 1.15M sh · $19.87M · Q2 2026
- BNY Mellon 1.02M sh · $17.57M · Q2 2026
- Principal Global Investors 991.82K sh · $17.17M · Q2 2026
- Fidelity Management & Research (FMR) 825.12K sh · $14.28M · Q2 2026